Results 281 to 290 of about 693,895 (386)

Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

open access: yesClinical Infectious Diseases, 2018
Tilly A. Varughese   +11 more
semanticscholar   +1 more source

Engineering antibodies with cancer‐associated binding sites

open access: yesBMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian   +4 more
wiley   +1 more source

Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials

open access: yesHaematologica, 2014
Elisabet E Manasanch   +6 more
doaj   +1 more source

Purification and Properties of a Lymphoid Acid Ribonuclease

open access: hybrid, 1969
Subrata Kumar Biswas   +1 more
openalex   +1 more source

5‐Aza combined with VPA reprograms human T lineage acute leukemia Jurkat cells into B‐cell‐like cells by epigenetic activation of PAX5

open access: yesBiotechnology Progress, EarlyView.
Abstract Epigenetic regulation plays an important role in cell fate reprogramming. Here, we found that inhibitors of epigenetic modifiers, including VPA, TSA, and 5‐Aza‐2'‐deoxycytidine, can induce phenotypic transformation from Jurkat cells into B‐cell‐like cells. When Jurkat cells were treated with 5‐Aza combined with VPA, B cell and stem cell marker
Wenjin Xi   +11 more
wiley   +1 more source

Tumor-associated macrophages in diffuse large B-cell lymphoma

open access: yesHaematologica, 2015
Robert Kridel   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy